January 30, 2024
Business Insider: Frustrated by healthcare's failings, the rich are investing in biotech to live longer and healthier
This feature highlights entrepreneurs, like R360 Member Peter Fioretti, who are motivated by personal health challenges to look at investment in biotech and healthcare technology. Peter shares his keen interest in longevity research and sheds light on the hurdles involved in investing in biotech opportunities...
This feature highlights entrepreneurs, like R360 Member Peter Fioretti, who are motivated by personal health challenges to look at investment in biotech and healthcare technology. Peter shares his keen interest in longevity research and sheds light on the hurdles involved in investing in biotech opportunities.
Disclosure: R360 is not an investment adviser. Information provided within is for educational purposes only and should not be construed, nor is intended to be, investment advice or a recommendation to invest in any types of securities. R360’s views are subject to change at any point without notice. No investment decision should be made based solely on the content herein and only a financial professional should be engaged for providing investment advice and recommendations. Past performance is not an indication of future returns.
